Description: Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
Home Page: www.gdkbio.com
12 Yujin Road
Taizhou,
225300
China
Phone:
86 523 8620 5860
Officers
| Name | Title |
|---|---|
| Mr. Jun Yu | Chairman & GM |
| Mr. Changyong Fan | Deputy GM, CFO & Sec. of the Board |
| Mr. Jianguo Xia | Deputy GM & Director |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 150 |
| Price-to-Book MRQ: | 2.7097 |
| Price-to-Sales TTM: | 15.2132 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 421 |